← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 DELISTED DermTech, Inc. Common Stock DMTK	22	+1	+5%	$106M
77	77 Mesoblast MESO $1.81B	22	-7	-24%	$14.3M
78	78 Capricor Therapeutics CAPR $423M	19	-1	-5%	$3.25M
79	79 Imunon IMNN $5.95M	19	-3	-14%	$2.52M
80	80 Krystal Biotech KRYS $9.77B	17	+5	+42%	$35.5M
81	81 Fulgent Genetics FLGT $587M	16	-4	-20%	$6.01M
82	CYAD 82 DELISTED Celyad Oncology SA American Depositary Shares CYAD	12	+3	+33%	$21.4M
83	83 DELISTED Orgenesis Inc. Common Stock ORGS	10	0	0%	$1.62M
84	84 Eterna Therapeutics ERNA $2.53M	8	0	0%	$4.82M
85	85 DELISTED Scorpius Holdings, Inc. SCPX	8	+4	+100%	$2.19M
86	86 Benitec Biopharma BNTC $295M	6	0	0%	$1.85M
87	87 Genprex GNPX $1.88M	4	+3	+300%	$7.96M
88	88 Enlivex Ltd ENLV $4.46M	3	-1	-25%	$169K
89	ACHL 89 DELISTED Achilles Therapeutics ACHL	–	–	–	–
90	90 DELISTED Arcellx ACLX	–	–	–	–
91	91 Adaptive Biotechnologies ADPT $4.08B	–	–	–	–
92	AKUS 92 DELISTED Akouos Inc AKUS	–	–	–	–
93	93 Allogene Therapeutics ALLO $463M	–	–	–	–
94	94 ALPS Group Inc ALPS $56.4M	–	–	–	–
95	95 Artiva Biotherapeutics ARTV $296M	–	–	–	–
96	96 BridgeBio Pharma BBIO $13.1B	–	–	–	–
97	97 BioCardia BCDA $14.2M	–	–	–	–
98	98 Beam Therapeutics BEAM $2.55B	–	–	–	–
99	99 Bionano Genomics BNGO $16.1M	–	–	–	–
100	100 Burning Rock Biotech BNR $165M	–	–	–	–